Drug Database · Clinicians

Fluticasone + Umeclidinium + Vilanterol

Brands (1) Trelegy ElliptaShow all

Adrenergic-anticholinergic- corticosteroid combination PH FDA category
Fixed-dose combination.

Rx · Prescription drug1 PH product
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Chronic rhinosinusitis with nasal polyps (CRSwNP) in adults. US FDA label

  • umeclidinium no separate page
  • vilanterol no separate page

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Dry powder for inhalation: 100 mcg/62.5 mcg/25 mcg

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Fluticasone + Umeclidinium + Vilanterol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Fluticasone + Umeclidinium + Vilanterol
Package insert
Trelegy ElliptaFluticasone Furoate + Umeclidinium (As Bromide) + Vilanterol (As Trifenatate)
100mcg/ 62.5 mcg/25mcg Dry Powder For InhalationAlu blister strip fitted in a plastic device inhaler enclosed in sealed foil laminate tray with desiccant packet x 30 actuation doses (Box of 1's) and 14 actuation doses (Box of 1's) [as Physician's Sample]
Rx
Glaxo Operations UK LTD.United Kingdom
GlaxoSmithKline Philippines, Inc.
DR-XY47366
Sep 8, 2029

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .